Journal
NATURE MEDICINE
Volume 27, Issue 6, Pages 1006-+Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41591-021-01357-y
Keywords
-
Funding
- Australian Government Department of Health and Ageing
- NHMRC [1196749, 1196755, 1128984, 1213110, 1110067]
- Cancer Council Victoria Dunlop Fellowship
- Howard Hughes Medical Institute international research scholarship
- CSL Centenary fellowship
- NHMRC postgraduate scholarship
- Cancer Institute of NSW Future Research Leader Fellowship [15-1-01]
- NHMRC/MRFF investigator grant [1195030]
- Snowdome Foundation/Maddie Riewoldt's vision
- George and Yolanda Klempfner AO fellowship
- Gilead
- National Health and Medical Research Council of Australia [1196749, 1196755, 1128984, 1110067] Funding Source: NHMRC
Ask authors/readers for more resources
People with HIV have a higher prevalence of clonal hematopoiesis (CH) compared to those without HIV, suggesting a selective advantage for CH emergence in the context of chronic infection and inflammation related to HIV infection. The most common mutated genes in this context were DNMT3A, TET2, and ASXL1. CH and HIV infection were independently associated with increases in blood parameters and biomarkers associated with inflammation.
People with human immunodeficiency virus (HIV) have higher rates of certain comorbidities, particularly cardiovascular disease and cancer, than people without HIV1-5. In view of observations that somatic mutations associated with age-related clonal hematopoiesis (CH) are linked to similar comorbidities in the general population(6-10), we hypothesized that CH may be more prevalent in people with HIV. To address this issue, we established a prospective cohort study, the ARCHIVE study (NCT04641013), in which 220 HIV-positive and 226 HIV-negative participants aged 55 years or older were recruited in Australia. Demographic characteristics, clinical data and peripheral blood were collected to assess the presence of CH mutations and to identify potential risk factors for and clinical sequelae of CH. In total, 135 CH mutations were identified in 100 (22.4%) of 446 participants. CH was more prevalent in HIV-positive participants than in HIV-negative participants (28.2% versus 16.8%, P = 0.004), overall and across all age groups; the adjusted odds ratio for having CH in those with HIV was 2.16 (95% confidence interval 1.34-3.48, P = 0.002). The most common genes mutated overall were DNMT3A (47.4%), TET2 (20.0%) and ASXL1 (13.3%). CH and HIV infection were independently associated with increases in blood parameters and biomarkers associated with inflammation. These data suggest a selective advantage for the emergence of CH in the context of chronic infection and inflammation related to HIV infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available